• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Decision aids maybe be underutilized in treating prostate cancer

byAshley AaroeandJames Jiang
March 12, 2015
in Chronic Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Radiation oncologists and urologists surveyed in this study did not commonly use decision aids when discussing treatment options with patients.

2. The most commonly cited barriers to use of decisions aids were the perception that their ability to estimate the risk of recurrence was superior to the decision aid, as well as that patients could not process information from the decision aid.

Evidence Rating Level: 4 (Below Average) 

Study Rundown: There are a variety of modalities used to treat clinically localized prostate cancer, including surgery, surveillance, radiotherapy, or a combination thereof. The decision hinges on clinical practice guidelines based on previously developed risk stratifications, but is also heavily dependent on the patient and what long-term risks and side effects of treatment they are willing to shoulder. As a means of better involving patients in the shared decision making between them and their care providers, various written ‘decision aids’ have been developed which clearly explain and compare options. Decision aids are written guides that can help patients and physicians converse about treatment options for prostate cancer. Previous studies have suggested that decision aids are a benefit to patients.

This study was designed to assess the use of clinical decision aids and clinician attitudes towards decision aids. It was found that about one third of clinicians used decision aids in practice, and it was commonly believed that their ability to estimate recurrence was superior to that of decision aids. Limitations of the study include the survey methodology which relies on respondent self-reporting of behavior. Despite multiple attempts to contact non-responders, ultimately there was only a 45% response rate, which limits interpretation of the data.

Click to read the study, published today in JAMA Internal Medicine

Click to read an invited commentary in JAMA Internal Medicine

RELATED REPORTS

Plant-based diets may be associated with lower risk of aggressive prostate cancer

Wellness Check: Nutrition

#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer

Relevant Reading: Decision aids to help people who are facing health treatment or screening decisions

In-Depth [survey]: This survey study involved radiation oncologists and urologists who were randomly selected from the American Medical Association Physician Masterfile. The finalized form of the survey assessed use of decision aids (DAs) in clinical practice, familiarity and usefulness of DAs, perceptions about barriers towards DAs, and trust in other organizations promoting DAs for prostate cancer. The final survey was sent to 1422 physicians, and a $10 incentive was provided for completing the survey.

Ultimately, 641 physicians responded for an overall response rate of 45.1%, which was not significantly different between radiation oncologists and urologists. Only 35.5% of those surveyed used a decision aid in their clinical practice. The most commonly cited barriers were the perception that the respondent’s ability to estimate the risk of recurrence was superior to that of the decision aid, as well as that the average patient could not process information from the decision aid. 16.5% of respondents felt that decision aids were very useful, and only 9.2% were “very confident” that using decision aids improves treatment decisions.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: prostate cancer
Previous Post

Adding bevacizumab may not improve breast cancer survival

Next Post

Stepped-care management useful for chronic pain treatment in veterans (ESCAPE Trial)

RelatedReports

Vegetarian diet may lower incidence of colorectal cancer
Lifestyle

Plant-based diets may be associated with lower risk of aggressive prostate cancer

January 27, 2023
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets
Wellness

Wellness Check: Nutrition

January 26, 2023
#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer
StudyGraphics

#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer

January 4, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 2

November 22, 2022
Next Post
Stepped-care management useful for chronic pain treatment in veterans (ESCAPE Trial)

Stepped-care management useful for chronic pain treatment in veterans (ESCAPE Trial)

Appropriate use criteria for angiography may frequently miss obstructive coronary artery disease

Appropriate use criteria for angiography may frequently miss obstructive coronary artery disease

Weekly dalbavancin noninferior to daily therapy for acute skin infection [DISCOVER 1 and 2 Trials]

Novel vaccine cocktail treats Staphylococcus aureus infections in mice (PreClinical)

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options